Department of Hematology and Blood Stem Cell Transplantation ( 292202)

Prof. Dr. med.

Uwe Platzbecker

Specialized in: hematology, blood stem cell transplantation

Curriculum vitae keyboard_arrow_down

• Since 2015 Appointment as Transcampus Professor of Hematology at the Faculty of Life Science and Medicine at King’s College London (UK) 
• Since 2014 Head of the section of hematology, Dept. of Internal Medicine I, University Hospital “Carl Gustav Carus” at the TU Dresden 
• Since 2012 Appointment as Professor of Translational Hematology (W2), TU Dresden 
• 2006 Habilitation (Privatdozent) 
• 2005 Senior physician and Head of Hematology out-patient department, Dept. of internal Medicine I, University Hospital “Carl Gustav Carus” at the TU Dresden 
• Since 2002 Dept. of internal Medicine I, University Hospital “Carl Gustav Carus”, at the TU Dresden 
• 2001-2002 Postdoc supported by the Humboldt-Foundation (Feodor Lynen Project) at the Fred Hutchinson Cancer Research Center, Prof. Dr. Deeg, Seattle, USA 
• 1998-2001 Dept. of internal Medicine I, University Hospital “Carl Gustav Carus” at the TU Dresden 
• 1998 Medical practice for Radiology, Grosche/Hupke/Lautenbach, Dresden 
• 1996-1998 Heart Center Dresden, Clinic for Cardio-and Thoracic Vascular Surgery, TU Dresden 
• Other Experience and Professional Memberships Professional appointments: 
• Since 2014 Chair medical ethics committee of the TU Dresden 
• Since 2013 Chairman European MDS studies coordination office (EMSCO) by the ELN 
• Since 2012 Co-Chairman MDS EHA SWG (Chair: P. Fenaux) 

Memberships:

• Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO) 
• American Society of Hematology (ASH) 
• European Haematology Association (EHA) 
• Study Alliance Leukemia (SAL) 
• Deutsch-Österreichisch-Schweizerische MDS Studiengruppe (DACH) 
• European Leukemia Net (ELN) 
• Gesellschaft für Thrombose und Hämostaseologie (GTH)

Honors

• 2014 EHA educational presentation 
• 2013 ASH educational presentation 
• 2012 Poster award, DGHO 
• 2010 Best Abstract, European Leukemia Net meeting 
• 2009 Poster award, 10th International Symposium on MDS 
• 2006 Travel award, American Society of Hematology (ASH) 
• 2006 Chugai Science Award

Publications keyboard_arrow_down

https://www.ncbi.nlm.nih.gov/pubmed/?term=Platzbecker+Uwe

The Department of Hematology and Blood Stem Cell Transplantation under the direction of Prof. Dr. med. Uwe Platzbecker, which is part of the Internal Medicine I at the University Hospital in Dresden, offers patients the most advanced diagnosis and a top-class treatment. The Department is focused on the treatment of maglinant diseases of the hematopoietic and lymphatic systems. These primarily include acute and chronic leukemias (AML, ALL, CML, CLL), lymphomas (Non-Hodgkin and Hodgkin), multiple myeloma (plasmacytoma), myelodysplastic syndromes (MDS). Moreover, the University Hospital in Dresden also provides diagnosis and treatment of rare benign, congenital or acquired blood disorders. 

The University Hospital Carl Gustav Carus Dresden has the following cutting-edge treatments: immunotherapy, chemotherapy and therapy involving the use of new targeted drugs. These treatments allow planning and provision of the adapted / individualized treatment for every patient. In addition to medical care in the state-of-the-art outpatient departments, You can also use a day hospital for both treatment and follow-up care. Over the years, patients with congenital and acquired blood clotting disorders have been treated in the outpatient clinic (haemostasiology). The team of the Department under the direction of Prof. Dr. med. Uwe Platzbecker has a special competence in allogenous and autologous blood stem cell transplantation. The Transplantation Unit is one of the largest institutions of its kind in Germany and certified by the European JACEI Committee (www.jacie.org) according to the most advanced quality standards. 

The Department of Hematology at the University Hospital Carl Gustav Carus Dresden has outstanding laboratory opportunities in order to diagnose hematologic diseases. Particularly, these include bone marrow cytology, cytogenetics and molecular genetics. Therefore, there are diagnosed not only all patients of the Department of Internal Medicine I, but also the patients referred by the order of the external cooperating partners.